Pamorelin LA
Pamorelin LA is an originator product from Debiopharm Research & Manufacturing SA and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 136.60 to CHF 657.55 depending on the pack; the patient co-payment is 10 per cent plus the deductible.
Core data
- Authorisation holder
- Debiopharm Research & Manufacturing SA
- ATC code
- L02AE04
- IT group
- 07.16.20 Hormone
- Active substances
- Triptorelinum
- Preparation type
- Originator product
- On the SL since
- 01/07/2005
- Last price change
- 01/02/2023
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Trockensub 3.75 mg c Solv (Adapter) | Set 1 Stk | CHF 110.49 | CHF 136.60 | 01/02/2019 | A | 7680528150017 |
| Trockensub 11.25 mg c Solv (Adapter) | Set 1 Stk | CHF 320.02 | CHF 364.45 | 01/02/2019 | A | 7680563490017 |
| Trockensub 22.5 mg c Solv (Adapter) | Set 1 Stk | CHF 589.50 | CHF 657.55 | 01/02/2019 | A | 7680612380023 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
Lokalisiertes hormonabhängiges Prostatakarzinom mit hohem Risiko oder lokal fortgeschrittenes Prostatakarzinom, das in Kombination mit einer Strahlentherapie behandelt wird.
More preparations in this group
FAQ
Is Pamorelin LA covered by Swiss health insurance?
Yes, but only under conditions. Pamorelin LA is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Pamorelin LA cost in Switzerland?
The public price is the maximum price set by the FOPH and for Pamorelin LA ranges from CHF 136.60 to CHF 657.55 per pack. The ex-factory price ranges from CHF 110.49 to CHF 589.50. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages